Cancer survivor Guido (69) was terminal until he was selected for a new immunotherapy: what does the treatment entail? | Medical

INTERVIEWGuido Wouters (69) was doomeduntil he was picked up by the Antwerp University Hospital (UZA) for a new immunotherapy against his lymphatic cancer. A year later, Guido is still cancer-free. What does this new therapy mean for cancer science? And can any cancer be treated with it? The driving force behind the study, Prof. Dr. Sébastien Anguille, explains. “The results are spectacular.”